Mr. Speaker, I am not sure that there was a question in there.
Big pharma spends a lot of money on designing new drugs. The profit margin is what drives them to do that. There is going to be a cost involved. Just making it a universal plan does not necessarily bring down all those costs.
I recognize that provinces already have pharmacare plans in place, and that a national plan would work together with them. I recognize that. It would not all be a cost to the federal government, but the total cost in 2018 was $34 billion. What will the federal government's contribution be toward that, and how will the federal government fund that contribution?